Cargando…

Therapeutic application of CCK2R-targeting PP-F11: influence of particle range, activity and peptide amount

BACKGROUND: Targeted radionuclide therapy with high-energy beta-emitters is generally considered suboptimal to cure small tumours (<300 mg). Tumour targeting of the CCK2 receptor-binding minigastrin analogue PP-F11 was determined in a tumour-bearing mouse model at increasing peptide amounts. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Konijnenberg, Mark W, Breeman, Wout A P, de Blois, Erik, Chan, Ho Sze, Boerman, Otto C, Laverman, Peter, Kolenc-Peitl, Petra, Melis, Marleen, de Jong, Marion
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452684/ https://www.ncbi.nlm.nih.gov/pubmed/26116111 http://dx.doi.org/10.1186/s13550-014-0047-1

Ejemplares similares

Comparative biodistribution of 12 (111)In-labelled gastrin/CCK2 receptor-targeting peptides
por: Laverman, Peter, et al.
Publicado: (2011)

Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors
por: Roosenburg, Susan, et al.
Publicado: (2010)

Evaluation of CCK2 receptor binding ligands: the inheritance of Thomas Behr
por: Boerman, Otto C., et al.
Publicado: (2011)

In Vitro comparison of (213)Bi- and (177)Lu-radiation for peptide receptor radionuclide therapy
por: Chan, Ho Sze, et al.
Publicado: (2017)

Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma
por: Fröberg, Alida C., et al.
Publicado: (2009)

Radiochemical and analytical aspects of inter-institutional quality control measurements on radiopharmaceuticals
por: de Blois, Erik, et al.
Publicado: (2019)

A novel CCK(2)/gastrin receptor-localizing radiolabeled peptide probe for personalized diagnosis and therapy of patients with progressive or metastatic medullary thyroid carcinoma: a multicenter phase I GRAN-T-MTC study
por: Erba, Paola A., et al.
Publicado: (2018)

Influence of tumour size on the efficacy of targeted alpha therapy with (213)Bi-[DOTA(0),Tyr(3)]-octreotate
por: Chan, Ho Sze, et al.
Publicado: (2016)

Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumours
por: Melis, Marleen, et al.
Publicado: (2009)

A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues
por: Schroeder, Rogier P. J., et al.
Publicado: (2010)

Optimizing labelling conditions of (213)Bi-DOTATATE for preclinical applications of peptide receptor targeted alpha therapy
por: Chan, Ho Sze, et al.
Publicado: (2016)

Improved safety and efficacy of (213)Bi-DOTATATE-targeted alpha therapy of somatostatin receptor-expressing neuroendocrine tumors in mice pre-treated with l-lysine
por: Chan, Ho Sze, et al.
Publicado: (2016)

Cholecystokinin (CCK) and its receptors (CCK1R and CCK2R) in chickens: functional analysis and tissue expression
por: Wan, Yiping, et al.
Publicado: (2022)

Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms
por: Fani, Melpomeni, et al.
Publicado: (2017)

Regulation of mammalian gastrin/CCK receptor (CCK2R) expression in vitro and in vivo
por: Ashurst, H Louise, et al.
Publicado: (2008)

Cholecystokinin Revisited: CCK and the Hunger Trap in Anorexia Nervosa
por: Cuntz, Ulrich, et al.
Publicado: (2013)

CCK2 receptors in chronic pain
por: LaVigne, Justin E., et al.
Publicado: (2022)

CCK reduces the food intake mainly through CCK1R in Siberian sturgeon (Acipenser baerii Brandt)
por: Zhang, Xin, et al.
Publicado: (2017)

Reduction of (68)Ge activity containing liquid waste from (68)Ga PET chemistry in nuclear medicine and radiopharmacy by solidification
por: de Blois, Erik, et al.
Publicado: (2010)

Effect of N-Terminal Peptide Modifications on In Vitro and In Vivo Properties of (177)Lu-Labeled Peptide Analogs Targeting CCK2R
por: Hörmann, Anton Amadeus, et al.
Publicado: (2023)

EANM guideline on the validation of analytical methods for radiopharmaceuticals
por: Gillings, Nic, et al.
Publicado: (2020)

Exploiting the Concept of Multivalency with (68)Ga- and (89)Zr-Labelled Fusarinine C-Minigastrin Bioconjugates for Targeting CCK2R Expression
por: Summer, Dominik, et al.
Publicado: (2018)

Rapid discovery of new leads for difficult targets: application to CCK2 and 11beta-HSD1
por: Cheeseright, T, et al.
Publicado: (2008)

Renal uptake of different radiolabelled peptides is mediated by megalin: SPECT and biodistribution studies in megalin-deficient mice
por: Vegt, Erik, et al.
Publicado: (2010)

A GLP-1:CCK fusion peptide harnesses the synergistic effects on metabolism of CCK-1 and GLP-1 receptor agonism in mice
por: Hornigold, David C., et al.
Publicado: (2018)

Optimized LC-MS/MS Method for the Detection of ppCCK(21–44): A Surrogate to Monitor Human Cholecystokinin Secretion
por: Foreman, Rachel E., et al.
Publicado: (2023)

SUN-334 Evaluation of the CCK-2 Receptor Agonist (177)Lu-PP-F11N for PRRT of Medullary Thyroid Carcinoma: Results of a Phase 0 "Lumed" Study
por: Rottenburger, Christof, et al.
Publicado: (2019)

CCK Response Deficiency in Synphilin-1 Transgenic Mice
por: Smith, Wanli W., et al.
Publicado: (2015)

Rediscovery of Ceruletide, a CCK Agonist, as an Analgesic Drug
por: Keppel Hesselink, Jan M
Publicado: (2020)

Radiolabelled peptides for oncological diagnosis
por: Laverman, Peter, et al.
Publicado: (2012)

First preclinical evaluation of [(225)Ac]Ac-DOTA-JR11 and comparison with [(177)Lu]Lu-DOTA-JR11, alpha versus beta radionuclide therapy of NETs
por: Handula, Maryana, et al.
Publicado: (2023)

Proposal to Increase the Amount of the Contract for Pipework for the pp Project
Publicado: (1981)

Introduction of a SiFA Moiety into the D-Glutamate Chain of DOTA-PP-F11N Results in Radiohybrid-Based CCK-2R-Targeted Compounds with Improved Pharmacokinetics In Vivo
por: Holzleitner, Nadine, et al.
Publicado: (2022)

Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals
por: Gillings, Nic, et al.
Publicado: (2021)

The Role of Gastrin and CCK Receptors in Pancreatic Cancer and other Malignancies
por: Smith, Jill P., et al.
Publicado: (2016)

Over-expression of CCK1 Receptor Reverse Morphine Dependence
por: Hao, Lijing, et al.
Publicado: (2018)

Neural circuit mechanisms of the cholecystokinin (CCK) neuropeptide system in addiction
por: Ma, Yihe, et al.
Publicado: (2022)

Effects of attenuation map accuracy on attenuation-corrected micro-SPECT images
por: Wu, Chao, et al.
Publicado: (2013)

DOPAMINE AND OBSESSIVE DISORDER: A CLINICAL STUDY WITH CCK AND METHYL PHENIDATE
por: Ananth, J., et al.
Publicado: (1992)

Drupal's building blocks: quickly building websites with CCK, Views and Panels
por: Miles, Earl, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_s73f77t23rfdiam37hf0pvr37k